Showing results (401-410 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|December 19, 2024
Infarct Growth in Patients with Emergent Large Vessel Occlusion Stroke Transferred for Endovascular ThrombectomyXiangjun Xu, Yujuan Zhu, Yapeng Guo, et al.
Neurology and Therapy|January 4, 2025
Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White AdultsRamesh R Boinpally, Brian McNamee
Neurology and Therapy|January 4, 2024
Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) StudyEtsuko Awaki, Takao Takeshima, Yasuhiko Matsumori, et al.
Neurology and Therapy|December 2, 2023
Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting ConditionsLuis Genis-Najera, Maria Elena Sañudo-Maury
Neurology and Therapy|November 30, 2023
Association of Atrial Fibrillation with Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results from a Multicenter Study in ChinaXiaoling Pan, Yingjian Pei, Meixia Zhang, et al.
Neurology and Therapy|January 20, 2024
Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with SchizophreniaWenyan Wang, Xiaofeng Wang, Ying Dong, et al.
Neurology and Therapy|January 18, 2024
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER StudyPatricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, et al.
Neurology and Therapy|January 11, 2024
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary PerspectivesMark S Freedman, Patricia K Coyle, Kerstin Hellwig, et al.
Neurology and Therapy|April 6, 2024
Donanemab in Japanese Patients with Early Alzheimer's Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized TrialShoichiro Sato, Naohisa Hatakeyama, Shinji Fujikoshi, et al.
Neurology and Therapy|March 26, 2024
REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support ProgramMatthias Schwab, Andrew Chan, Anna-Katharina Eser, et al.
Pageof 95